OxUs

Executive Summary

OxUs America is an ISO 13485 certified and FDA registered OEM supplier specializing in contract engineering, contract manufacturing, and aftermarket services for respiratory medical devices and gas separation technology. Headquartered in Lake Orion, Michigan, the company serves as a reliable partner for respiratory equipment manufacturers, providing design, production, and lifecycle support. Founded in 2018, OxUs has positioned itself within the growing respiratory care market, which continues to see demand driven by chronic respiratory diseases, aging populations, and post-pandemic preparedness. Its capabilities in gas separation (e.g., oxygen concentrators) offer differentiation in a competitive landscape. As a private entity with no disclosed funding or valuation, OxUs operates with a lean profile, focusing on operational excellence and customer partnerships. The company's growth trajectory is tied to its ability to win new contracts and expand its manufacturing capacity. While not a drug developer, its role as a critical supplier to the respiratory device ecosystem provides steady revenue potential. However, the lack of publicly available financials or major product milestones limits visibility into near-term performance. Overall, OxUs represents a stable but low-visibility opportunity in the medical device contract manufacturing space, with moderate upside tied to industry tailwinds.

Upcoming Catalysts (preview)

• Q3 2026Securing large contract with major respiratory device OEM45% success
• Q4 2026Facility expansion or new certification (e.g., MDSAP)30% success
• TBDPartnership or acquisition by larger medical device manufacturer20% success